Insulet appoints two executives
Dr. Ly is an expert in artificial pancreas technologies. Most recently, she has held positions at both Stanford University and University of Western Australia, as Clinical Assistant Professor and Research Assistant Professor, respectively.
Prior to her time at Stanford, Dr. Ly was a Consultant Pediatric Endocrinologist in the Department of Endocrinology and Diabetes at Princess Margaret Hospital for Children in Perth, Australia.
Dr. Ly holds a Bachelor of Medicine and Surgery, a Diploma of Child Health and a PhD in Pediatrics and Pediatrics Endocrinology from the University of Western Australia.
She is also a fellow of the Royal Australasian College of Physicians with Specialist Qualifications in Pediatrics Endocrinology
In addition, Brittany Bradrick has been appointed Vice President, Strategy and Corporate Development, a newly-created position.
Ms. Bradrick joins Insulet from Abbott Diabetes Care, where she was Director, Business Development and Alliance Management, responsible for leading the division’s global business development efforts, including strategy, acquisitions, dispositions, global partnerships and licensing of intellectual property and technology.
Prior to Abbott, Ms. Bradrick advised life science companies for over ten years as an investment banker with Piper Jaffray, Credit Suisse and JP Morgan.
Ms. Bradrick earned a B.S. in Business Administration from the University of Missouri and a MBA from the Johnson Graduate School of Management at Cornell University. ■
What to read next
LATEST MOVES FROM Massachusetts
- Tetraphase Pharma appoints Kamalam Unninayar as CFO
- Boston Biomedical appoints Edgar Braendle as vice president
- Analogic Corporation appoints Joseph Whitters to board
- Eleven Biotherapeutics appoints Richard F. Fitzgerald as interim CFO
- Acer Therapeutics appoints William T. Andrews as CMO
More inside POST
New CEOs have 100 days to boost stock prices Leadership